Analyst Price Targets — NEXI
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| August 16, 2022 8:04 am | — | Barclays | $2.00 | $1.19 | Benzinga | Barclays Maintains Overweight on NexImmune, Lowers Price Target to $2 |
| August 16, 2022 7:28 am | — | Raymond James | $3.00 | $1.26 | Benzinga | Raymond James Maintains Outperform on NexImmune, Lowers Price Target to $3 |
| June 1, 2022 7:28 am | — | BTIG | $5.00 | $2.28 | Benzinga | BTIG Initiates Coverage On NexImmune with Buy Rating, Announces Price Target of $5 |
Latest News for NEXI
Italian state investor CDP to raise stake in payments group Nexi
Italian state investor CDP Equity plans to raise its stake in payments group Nexi to as much as 29.9%, it said on Monday, bolstering a player in a sector viewed as increasingly strategic.
Italy's CDP against selling stake in Nexi, sources say
Italy's state lender Cassa Depositi e Prestiti (CDP) has no plans to divest from payments group Nexi NEXII.Mi, two sources familiar with the matter said on Wednesday.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for NEXI.
U.S. House Trading
No House trades found for NEXI.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.